Novartis AG (NVS)
154.03
-1.05
(-0.68%)
USD |
NYSE |
Apr 02, 16:00
154.00
-0.03
(-0.02%)
After-Hours: 20:00
Novartis Shareholders Equity (Quarterly) : 46.13B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Amgen, Inc. | 8.658B |
| AstraZeneca PLC | 48.67B |
| Gilead Sciences, Inc. | 22.70B |
| GSK Plc | 22.03B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.57B |
| Total Liabilities (Quarterly) | 69.02B |
| Debt to Equity Ratio | 0.7669 |
| Current Ratio | 1.117 |
| Net Debt Paydown Yield | -0.24% |